Ono Pharmaceutical - OPHLY Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 3
  • Breakdown:
  • 1 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$6.33
▼ -0.01 (-0.16%)

This chart shows the closing price for OPHLY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ono Pharmaceutical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OPHLY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OPHLY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 3 analysts offering 12 month price targets for Ono Pharmaceutical in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $6.33.

This chart shows the closing price for OPHLY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Ono Pharmaceutical.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/16/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/16/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/14/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/12/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/11/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/11/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
5/10/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/9/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
4/28/2023The Goldman Sachs GroupDowngradeNeutral ➝ Sell
1/3/2023Jefferies Financial GroupDowngradeBuy ➝ Hold
8/12/2022CitigroupDowngradeBuy ➝ Neutral
1/25/2021Jefferies Financial GroupUpgradeHold ➝ Buy
5/27/2020MizuhoUpgradeNeutral ➝ Buy
4/17/2020CLSAInitiated CoverageBuy
9/24/2019Jefferies Financial GroupInitiated CoverageHold
6/20/2019Morgan StanleyDowngradeOverweight ➝ Neutral
3/5/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
(Data available from 6/9/2018 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/11/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/11/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/10/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/9/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/11/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/10/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/10/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/9/2023

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Ono Pharmaceutical logo
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
Read More

Today's Range

Now: $6.33
Low: $6.28
High: $6.43

50 Day Range

MA: $6.54
Low: $6.02
High: $7.04

52 Week Range

Now: $6.33
Low: $5.98
High: $9.50

Volume

64,348 shs

Average Volume

115,689 shs

Market Capitalization

N/A

P/E Ratio

1.39

Dividend Yield

1.43%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Ono Pharmaceutical?

The following sell-side analysts have issued research reports on Ono Pharmaceutical in the last year: Citigroup Inc., Jefferies Financial Group Inc., and The Goldman Sachs Group, Inc..
View the latest analyst ratings for OPHLY.

What is the current price target for Ono Pharmaceutical?

0 Wall Street analysts have set twelve-month price targets for Ono Pharmaceutical in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Ono Pharmaceutical in the next year.
View the latest price targets for OPHLY.

What is the current consensus analyst rating for Ono Pharmaceutical?

Ono Pharmaceutical currently has 1 sell rating and 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in OPHLY, but not buy more shares or sell existing shares.
View the latest ratings for OPHLY.

What other companies compete with Ono Pharmaceutical?

How do I contact Ono Pharmaceutical's investor relations team?

The company's listed phone number is (166) 263-5670. The official website for Ono Pharmaceutical is www.ono.co.jp. Learn More about contacing Ono Pharmaceutical investor relations.